Global Oncology Injection Drug Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Oncology Injection Drug market size is predicted to grow from US$ 179 million in 2025 to US$ 254 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.
An oncology injection drug refers to a medication administered by injection for the treatment of cancer. These drugs can be chemotherapy agents, targeted therapies, immunotherapies, or supportive medications.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Oncology Injection Drug Industry Forecast” looks at past sales and reviews total world Oncology Injection Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Oncology Injection Drug sales for 2025 through 2031. With Oncology Injection Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Injection Drug industry.
This Insight Report provides a comprehensive analysis of the global Oncology Injection Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncology Injection Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Injection Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Injection Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Injection Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Injection Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Oncology Injection Drug market?
What factors are driving Oncology Injection Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oncology Injection Drug market opportunities vary by end market size?
How does Oncology Injection Drug break out by Type, by Application?
The global Oncology Injection Drug market size is predicted to grow from US$ 179 million in 2025 to US$ 254 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.
An oncology injection drug refers to a medication administered by injection for the treatment of cancer. These drugs can be chemotherapy agents, targeted therapies, immunotherapies, or supportive medications.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Oncology Injection Drug Industry Forecast” looks at past sales and reviews total world Oncology Injection Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Oncology Injection Drug sales for 2025 through 2031. With Oncology Injection Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Injection Drug industry.
This Insight Report provides a comprehensive analysis of the global Oncology Injection Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncology Injection Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Injection Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Injection Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Injection Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Injection Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Organs
- Central Nervous System
- Circulatory/Musculoskeletal System
- Other
- Lymphoma
- Myeloma
- Prostate Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Taj Oncology
- S.G. Biopharm
- AdvaCare
- Merrimack
- Celgene
- Allos Therapeutics
- Ferring Pharmaceuticals
- Genzyme
- Eli Lilly
- Praecis Pharmaceuticals
- Millennium Pharmaceuticals
- Debiopharm
- Alza
- CordenPharma
- Pharmascience
What is the 10-year outlook for the global Oncology Injection Drug market?
What factors are driving Oncology Injection Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oncology Injection Drug market opportunities vary by end market size?
How does Oncology Injection Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Injection Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Oncology Injection Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Oncology Injection Drug by Country/Region, 2020, 2024 & 2031
2.2 Oncology Injection Drug Segment by Type
2.2.1 Organs
2.2.2 Central Nervous System
2.2.3 Circulatory/Musculoskeletal System
2.2.4 Other
2.3 Oncology Injection Drug Sales by Type
2.3.1 Global Oncology Injection Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Oncology Injection Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Oncology Injection Drug Sale Price by Type (2020-2025)
2.4 Oncology Injection Drug Segment by Application
2.4.1 Lymphoma
2.4.2 Myeloma
2.4.3 Prostate Cancer
2.4.4 Other
2.5 Oncology Injection Drug Sales by Application
2.5.1 Global Oncology Injection Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Oncology Injection Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Oncology Injection Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Oncology Injection Drug Breakdown Data by Company
3.1.1 Global Oncology Injection Drug Annual Sales by Company (2020-2025)
3.1.2 Global Oncology Injection Drug Sales Market Share by Company (2020-2025)
3.2 Global Oncology Injection Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Oncology Injection Drug Revenue by Company (2020-2025)
3.2.2 Global Oncology Injection Drug Revenue Market Share by Company (2020-2025)
3.3 Global Oncology Injection Drug Sale Price by Company
3.4 Key Manufacturers Oncology Injection Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oncology Injection Drug Product Location Distribution
3.4.2 Players Oncology Injection Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ONCOLOGY INJECTION DRUG BY GEOGRAPHIC REGION
4.1 World Historic Oncology Injection Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Oncology Injection Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Oncology Injection Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Oncology Injection Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Oncology Injection Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Oncology Injection Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oncology Injection Drug Sales Growth
4.4 APAC Oncology Injection Drug Sales Growth
4.5 Europe Oncology Injection Drug Sales Growth
4.6 Middle East & Africa Oncology Injection Drug Sales Growth
5 AMERICAS
5.1 Americas Oncology Injection Drug Sales by Country
5.1.1 Americas Oncology Injection Drug Sales by Country (2020-2025)
5.1.2 Americas Oncology Injection Drug Revenue by Country (2020-2025)
5.2 Americas Oncology Injection Drug Sales by Type (2020-2025)
5.3 Americas Oncology Injection Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Injection Drug Sales by Region
6.1.1 APAC Oncology Injection Drug Sales by Region (2020-2025)
6.1.2 APAC Oncology Injection Drug Revenue by Region (2020-2025)
6.2 APAC Oncology Injection Drug Sales by Type (2020-2025)
6.3 APAC Oncology Injection Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oncology Injection Drug by Country
7.1.1 Europe Oncology Injection Drug Sales by Country (2020-2025)
7.1.2 Europe Oncology Injection Drug Revenue by Country (2020-2025)
7.2 Europe Oncology Injection Drug Sales by Type (2020-2025)
7.3 Europe Oncology Injection Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Injection Drug by Country
8.1.1 Middle East & Africa Oncology Injection Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Oncology Injection Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Oncology Injection Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Oncology Injection Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oncology Injection Drug
10.3 Manufacturing Process Analysis of Oncology Injection Drug
10.4 Industry Chain Structure of Oncology Injection Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oncology Injection Drug Distributors
11.3 Oncology Injection Drug Customer
12 WORLD FORECAST REVIEW FOR ONCOLOGY INJECTION DRUG BY GEOGRAPHIC REGION
12.1 Global Oncology Injection Drug Market Size Forecast by Region
12.1.1 Global Oncology Injection Drug Forecast by Region (2026-2031)
12.1.2 Global Oncology Injection Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Oncology Injection Drug Forecast by Type (2026-2031)
12.7 Global Oncology Injection Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Taj Oncology
13.1.1 Taj Oncology Company Information
13.1.2 Taj Oncology Oncology Injection Drug Product Portfolios and Specifications
13.1.3 Taj Oncology Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Taj Oncology Main Business Overview
13.1.5 Taj Oncology Latest Developments
13.2 S.G. Biopharm
13.2.1 S.G. Biopharm Company Information
13.2.2 S.G. Biopharm Oncology Injection Drug Product Portfolios and Specifications
13.2.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 S.G. Biopharm Main Business Overview
13.2.5 S.G. Biopharm Latest Developments
13.3 AdvaCare
13.3.1 AdvaCare Company Information
13.3.2 AdvaCare Oncology Injection Drug Product Portfolios and Specifications
13.3.3 AdvaCare Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 AdvaCare Main Business Overview
13.3.5 AdvaCare Latest Developments
13.4 Merrimack
13.4.1 Merrimack Company Information
13.4.2 Merrimack Oncology Injection Drug Product Portfolios and Specifications
13.4.3 Merrimack Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merrimack Main Business Overview
13.4.5 Merrimack Latest Developments
13.5 Celgene
13.5.1 Celgene Company Information
13.5.2 Celgene Oncology Injection Drug Product Portfolios and Specifications
13.5.3 Celgene Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Celgene Main Business Overview
13.5.5 Celgene Latest Developments
13.6 Allos Therapeutics
13.6.1 Allos Therapeutics Company Information
13.6.2 Allos Therapeutics Oncology Injection Drug Product Portfolios and Specifications
13.6.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Allos Therapeutics Main Business Overview
13.6.5 Allos Therapeutics Latest Developments
13.7 Ferring Pharmaceuticals
13.7.1 Ferring Pharmaceuticals Company Information
13.7.2 Ferring Pharmaceuticals Oncology Injection Drug Product Portfolios and Specifications
13.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Ferring Pharmaceuticals Main Business Overview
13.7.5 Ferring Pharmaceuticals Latest Developments
13.8 Genzyme
13.8.1 Genzyme Company Information
13.8.2 Genzyme Oncology Injection Drug Product Portfolios and Specifications
13.8.3 Genzyme Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Genzyme Main Business Overview
13.8.5 Genzyme Latest Developments
13.9 Eli Lilly
13.9.1 Eli Lilly Company Information
13.9.2 Eli Lilly Oncology Injection Drug Product Portfolios and Specifications
13.9.3 Eli Lilly Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Eli Lilly Main Business Overview
13.9.5 Eli Lilly Latest Developments
13.10 Praecis Pharmaceuticals
13.10.1 Praecis Pharmaceuticals Company Information
13.10.2 Praecis Pharmaceuticals Oncology Injection Drug Product Portfolios and Specifications
13.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Praecis Pharmaceuticals Main Business Overview
13.10.5 Praecis Pharmaceuticals Latest Developments
13.11 Millennium Pharmaceuticals
13.11.1 Millennium Pharmaceuticals Company Information
13.11.2 Millennium Pharmaceuticals Oncology Injection Drug Product Portfolios and Specifications
13.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Millennium Pharmaceuticals Main Business Overview
13.11.5 Millennium Pharmaceuticals Latest Developments
13.12 Debiopharm
13.12.1 Debiopharm Company Information
13.12.2 Debiopharm Oncology Injection Drug Product Portfolios and Specifications
13.12.3 Debiopharm Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Debiopharm Main Business Overview
13.12.5 Debiopharm Latest Developments
13.13 Alza
13.13.1 Alza Company Information
13.13.2 Alza Oncology Injection Drug Product Portfolios and Specifications
13.13.3 Alza Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Alza Main Business Overview
13.13.5 Alza Latest Developments
13.14 CordenPharma
13.14.1 CordenPharma Company Information
13.14.2 CordenPharma Oncology Injection Drug Product Portfolios and Specifications
13.14.3 CordenPharma Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 CordenPharma Main Business Overview
13.14.5 CordenPharma Latest Developments
13.15 Pharmascience
13.15.1 Pharmascience Company Information
13.15.2 Pharmascience Oncology Injection Drug Product Portfolios and Specifications
13.15.3 Pharmascience Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Pharmascience Main Business Overview
13.15.5 Pharmascience Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Oncology Injection Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Oncology Injection Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Organs
Table 4. Major Players of Central Nervous System
Table 5. Major Players of Circulatory/Musculoskeletal System
Table 6. Major Players of Other
Table 7. Global Oncology Injection Drug Sales byType (2020-2025) & (K Pcs)
Table 8. Global Oncology Injection Drug Sales Market Share byType (2020-2025)
Table 9. Global Oncology Injection Drug Revenue byType (2020-2025) & ($ million)
Table 10. Global Oncology Injection Drug Revenue Market Share byType (2020-2025)
Table 11. Global Oncology Injection Drug Sale Price byType (2020-2025) & (USD/Pcs)
Table 12. Global Oncology Injection Drug Sale by Application (2020-2025) & (K Pcs)
Table 13. Global Oncology Injection Drug Sale Market Share by Application (2020-2025)
Table 14. Global Oncology Injection Drug Revenue by Application (2020-2025) & ($ million)
Table 15. Global Oncology Injection Drug Revenue Market Share by Application (2020-2025)
Table 16. Global Oncology Injection Drug Sale Price by Application (2020-2025) & (USD/Pcs)
Table 17. Global Oncology Injection Drug Sales by Company (2020-2025) & (K Pcs)
Table 18. Global Oncology Injection Drug Sales Market Share by Company (2020-2025)
Table 19. Global Oncology Injection Drug Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Oncology Injection Drug Revenue Market Share by Company (2020-2025)
Table 21. Global Oncology Injection Drug Sale Price by Company (2020-2025) & (USD/Pcs)
Table 22. Key Manufacturers Oncology Injection Drug Producing Area Distribution and Sales Area
Table 23. Players Oncology Injection Drug Products Offered
Table 24. Oncology Injection Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Oncology Injection Drug Sales by Geographic Region (2020-2025) & (K Pcs)
Table 28. Global Oncology Injection Drug Sales Market Share Geographic Region (2020-2025)
Table 29. Global Oncology Injection Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Oncology Injection Drug Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Oncology Injection Drug Sales by Country/Region (2020-2025) & (K Pcs)
Table 32. Global Oncology Injection Drug Sales Market Share by Country/Region (2020-2025)
Table 33. Global Oncology Injection Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Oncology Injection Drug Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Oncology Injection Drug Sales by Country (2020-2025) & (K Pcs)
Table 36. Americas Oncology Injection Drug Sales Market Share by Country (2020-2025)
Table 37. Americas Oncology Injection Drug Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Oncology Injection Drug Sales byType (2020-2025) & (K Pcs)
Table 39. Americas Oncology Injection Drug Sales by Application (2020-2025) & (K Pcs)
Table 40. APAC Oncology Injection Drug Sales by Region (2020-2025) & (K Pcs)
Table 41. APAC Oncology Injection Drug Sales Market Share by Region (2020-2025)
Table 42. APAC Oncology Injection Drug Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Oncology Injection Drug Sales byType (2020-2025) & (K Pcs)
Table 44. APAC Oncology Injection Drug Sales by Application (2020-2025) & (K Pcs)
Table 45. Europe Oncology Injection Drug Sales by Country (2020-2025) & (K Pcs)
Table 46. Europe Oncology Injection Drug Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Oncology Injection Drug Sales byType (2020-2025) & (K Pcs)
Table 48. Europe Oncology Injection Drug Sales by Application (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Oncology Injection Drug Sales by Country (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Oncology Injection Drug Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Oncology Injection Drug Sales byType (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Oncology Injection Drug Sales by Application (2020-2025) & (K Pcs)
Table 53. Key Market Drivers & Growth Opportunities of Oncology Injection Drug
Table 54. Key Market Challenges & Risks of Oncology Injection Drug
Table 55. Key IndustryTrends of Oncology Injection Drug
Table 56. Oncology Injection Drug Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Oncology Injection Drug Distributors List
Table 59. Oncology Injection Drug Customer List
Table 60. Global Oncology Injection Drug SalesForecast by Region (2026-2031) & (K Pcs)
Table 61. Global Oncology Injection Drug RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Oncology Injection Drug SalesForecast by Country (2026-2031) & (K Pcs)
Table 63. Americas Oncology Injection Drug Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Oncology Injection Drug SalesForecast by Region (2026-2031) & (K Pcs)
Table 65. APAC Oncology Injection Drug Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Oncology Injection Drug SalesForecast by Country (2026-2031) & (K Pcs)
Table 67. Europe Oncology Injection Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Oncology Injection Drug SalesForecast by Country (2026-2031) & (K Pcs)
Table 69. Middle East & Africa Oncology Injection Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Oncology Injection Drug SalesForecast byType (2026-2031) & (K Pcs)
Table 71. Global Oncology Injection Drug RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Oncology Injection Drug SalesForecast by Application (2026-2031) & (K Pcs)
Table 73. Global Oncology Injection Drug RevenueForecast by Application (2026-2031) & ($ millions)
Table 74.Taj Oncology Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 75.Taj Oncology Oncology Injection Drug Product Portfolios and Specifications
Table 76.Taj Oncology Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 77.Taj Oncology Main Business
Table 78.Taj Oncology Latest Developments
Table 79. S.G. Biopharm Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. S.G. Biopharm Oncology Injection Drug Product Portfolios and Specifications
Table 81. S.G. Biopharm Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 82. S.G. Biopharm Main Business
Table 83. S.G. Biopharm Latest Developments
Table 84. AdvaCare Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. AdvaCare Oncology Injection Drug Product Portfolios and Specifications
Table 86. AdvaCare Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 87. AdvaCare Main Business
Table 88. AdvaCare Latest Developments
Table 89. Merrimack Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Merrimack Oncology Injection Drug Product Portfolios and Specifications
Table 91. Merrimack Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 92. Merrimack Main Business
Table 93. Merrimack Latest Developments
Table 94. Celgene Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Celgene Oncology Injection Drug Product Portfolios and Specifications
Table 96. Celgene Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 97. Celgene Main Business
Table 98. Celgene Latest Developments
Table 99. AllosTherapeutics Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. AllosTherapeutics Oncology Injection Drug Product Portfolios and Specifications
Table 101. AllosTherapeutics Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 102. AllosTherapeutics Main Business
Table 103. AllosTherapeutics Latest Developments
Table 104.Ferring Pharmaceuticals Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 105.Ferring Pharmaceuticals Oncology Injection Drug Product Portfolios and Specifications
Table 106.Ferring Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 107.Ferring Pharmaceuticals Main Business
Table 108.Ferring Pharmaceuticals Latest Developments
Table 109. Genzyme Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Genzyme Oncology Injection Drug Product Portfolios and Specifications
Table 111. Genzyme Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 112. Genzyme Main Business
Table 113. Genzyme Latest Developments
Table 114. Eli Lilly Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Eli Lilly Oncology Injection Drug Product Portfolios and Specifications
Table 116. Eli Lilly Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 117. Eli Lilly Main Business
Table 118. Eli Lilly Latest Developments
Table 119. Praecis Pharmaceuticals Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Praecis Pharmaceuticals Oncology Injection Drug Product Portfolios and Specifications
Table 121. Praecis Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 122. Praecis Pharmaceuticals Main Business
Table 123. Praecis Pharmaceuticals Latest Developments
Table 124. Millennium Pharmaceuticals Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Millennium Pharmaceuticals Oncology Injection Drug Product Portfolios and Specifications
Table 126. Millennium Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 127. Millennium Pharmaceuticals Main Business
Table 128. Millennium Pharmaceuticals Latest Developments
Table 129. Debiopharm Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 130. Debiopharm Oncology Injection Drug Product Portfolios and Specifications
Table 131. Debiopharm Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 132. Debiopharm Main Business
Table 133. Debiopharm Latest Developments
Table 134. Alza Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 135. Alza Oncology Injection Drug Product Portfolios and Specifications
Table 136. Alza Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 137. Alza Main Business
Table 138. Alza Latest Developments
Table 139. CordenPharma Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 140. CordenPharma Oncology Injection Drug Product Portfolios and Specifications
Table 141. CordenPharma Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 142. CordenPharma Main Business
Table 143. CordenPharma Latest Developments
Table 144. Pharmascience Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 145. Pharmascience Oncology Injection Drug Product Portfolios and Specifications
Table 146. Pharmascience Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 147. Pharmascience Main Business
Table 148. Pharmascience Latest Developments
LIST OFFIGURES
Figure 1. Picture of Oncology Injection Drug
Figure 2. Oncology Injection Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oncology Injection Drug Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Oncology Injection Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Oncology Injection Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Oncology Injection Drug Sales Market Share by Country/Region (2024)
Figure 10. Oncology Injection Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Organs
Figure 12. Product Picture of Central Nervous System
Figure 13. Product Picture of Circulatory/Musculoskeletal System
Figure 14. Product Picture of Other
Figure 15. Global Oncology Injection Drug Sales Market Share byType in 2025
Figure 16. Global Oncology Injection Drug Revenue Market Share byType (2020-2025)
Figure 17. Oncology Injection Drug Consumed in Lymphoma
Figure 18. Global Oncology Injection Drug Market: Lymphoma (2020-2025) & (K Pcs)
Figure 19. Oncology Injection Drug Consumed in Myeloma
Figure 20. Global Oncology Injection Drug Market: Myeloma (2020-2025) & (K Pcs)
Figure 21. Oncology Injection Drug Consumed in Prostate Cancer
Figure 22. Global Oncology Injection Drug Market: Prostate Cancer (2020-2025) & (K Pcs)
Figure 23. Oncology Injection Drug Consumed in Other
Figure 24. Global Oncology Injection Drug Market: Other (2020-2025) & (K Pcs)
Figure 25. Global Oncology Injection Drug Sale Market Share by Application (2024)
Figure 26. Global Oncology Injection Drug Revenue Market Share by Application in 2025
Figure 27. Oncology Injection Drug Sales by Company in 2025 (K Pcs)
Figure 28. Global Oncology Injection Drug Sales Market Share by Company in 2025
Figure 29. Oncology Injection Drug Revenue by Company in 2025 ($ millions)
Figure 30. Global Oncology Injection Drug Revenue Market Share by Company in 2025
Figure 31. Global Oncology Injection Drug Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Oncology Injection Drug Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Oncology Injection Drug Sales 2020-2025 (K Pcs)
Figure 34. Americas Oncology Injection Drug Revenue 2020-2025 ($ millions)
Figure 35. APAC Oncology Injection Drug Sales 2020-2025 (K Pcs)
Figure 36. APAC Oncology Injection Drug Revenue 2020-2025 ($ millions)
Figure 37. Europe Oncology Injection Drug Sales 2020-2025 (K Pcs)
Figure 38. Europe Oncology Injection Drug Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Oncology Injection Drug Sales 2020-2025 (K Pcs)
Figure 40. Middle East & Africa Oncology Injection Drug Revenue 2020-2025 ($ millions)
Figure 41. Americas Oncology Injection Drug Sales Market Share by Country in 2025
Figure 42. Americas Oncology Injection Drug Revenue Market Share by Country (2020-2025)
Figure 43. Americas Oncology Injection Drug Sales Market Share byType (2020-2025)
Figure 44. Americas Oncology Injection Drug Sales Market Share by Application (2020-2025)
Figure 45. United States Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Oncology Injection Drug Sales Market Share by Region in 2025
Figure 50. APAC Oncology Injection Drug Revenue Market Share by Region (2020-2025)
Figure 51. APAC Oncology Injection Drug Sales Market Share byType (2020-2025)
Figure 52. APAC Oncology Injection Drug Sales Market Share by Application (2020-2025)
Figure 53. China Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. India Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 59. ChinaTaiwan Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Oncology Injection Drug Sales Market Share by Country in 2025
Figure 61. Europe Oncology Injection Drug Revenue Market Share by Country (2020-2025)
Figure 62. Europe Oncology Injection Drug Sales Market Share byType (2020-2025)
Figure 63. Europe Oncology Injection Drug Sales Market Share by Application (2020-2025)
Figure 64. Germany Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 65.France Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Oncology Injection Drug Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Oncology Injection Drug Sales Market Share byType (2020-2025)
Figure 71. Middle East & Africa Oncology Injection Drug Sales Market Share by Application (2020-2025)
Figure 72. Egypt Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 75.Turkey Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Oncology Injection Drug in 2025
Figure 78. Manufacturing Process Analysis of Oncology Injection Drug
Figure 79. Industry Chain Structure of Oncology Injection Drug
Figure 80. Channels of Distribution
Figure 81. Global Oncology Injection Drug Sales MarketForecast by Region (2026-2031)
Figure 82. Global Oncology Injection Drug Revenue Market ShareForecast by Region (2026-2031)
Figure 83. Global Oncology Injection Drug Sales Market ShareForecast byType (2026-2031)
Figure 84. Global Oncology Injection Drug Revenue Market ShareForecast byType (2026-2031)
Figure 85. Global Oncology Injection Drug Sales Market ShareForecast by Application (2026-2031)
Figure 86. Global Oncology Injection Drug Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Injection Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Oncology Injection Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Oncology Injection Drug by Country/Region, 2020, 2024 & 2031
2.2 Oncology Injection Drug Segment by Type
2.2.1 Organs
2.2.2 Central Nervous System
2.2.3 Circulatory/Musculoskeletal System
2.2.4 Other
2.3 Oncology Injection Drug Sales by Type
2.3.1 Global Oncology Injection Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Oncology Injection Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Oncology Injection Drug Sale Price by Type (2020-2025)
2.4 Oncology Injection Drug Segment by Application
2.4.1 Lymphoma
2.4.2 Myeloma
2.4.3 Prostate Cancer
2.4.4 Other
2.5 Oncology Injection Drug Sales by Application
2.5.1 Global Oncology Injection Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Oncology Injection Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Oncology Injection Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Oncology Injection Drug Breakdown Data by Company
3.1.1 Global Oncology Injection Drug Annual Sales by Company (2020-2025)
3.1.2 Global Oncology Injection Drug Sales Market Share by Company (2020-2025)
3.2 Global Oncology Injection Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Oncology Injection Drug Revenue by Company (2020-2025)
3.2.2 Global Oncology Injection Drug Revenue Market Share by Company (2020-2025)
3.3 Global Oncology Injection Drug Sale Price by Company
3.4 Key Manufacturers Oncology Injection Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oncology Injection Drug Product Location Distribution
3.4.2 Players Oncology Injection Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ONCOLOGY INJECTION DRUG BY GEOGRAPHIC REGION
4.1 World Historic Oncology Injection Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Oncology Injection Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Oncology Injection Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Oncology Injection Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Oncology Injection Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Oncology Injection Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oncology Injection Drug Sales Growth
4.4 APAC Oncology Injection Drug Sales Growth
4.5 Europe Oncology Injection Drug Sales Growth
4.6 Middle East & Africa Oncology Injection Drug Sales Growth
5 AMERICAS
5.1 Americas Oncology Injection Drug Sales by Country
5.1.1 Americas Oncology Injection Drug Sales by Country (2020-2025)
5.1.2 Americas Oncology Injection Drug Revenue by Country (2020-2025)
5.2 Americas Oncology Injection Drug Sales by Type (2020-2025)
5.3 Americas Oncology Injection Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Injection Drug Sales by Region
6.1.1 APAC Oncology Injection Drug Sales by Region (2020-2025)
6.1.2 APAC Oncology Injection Drug Revenue by Region (2020-2025)
6.2 APAC Oncology Injection Drug Sales by Type (2020-2025)
6.3 APAC Oncology Injection Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oncology Injection Drug by Country
7.1.1 Europe Oncology Injection Drug Sales by Country (2020-2025)
7.1.2 Europe Oncology Injection Drug Revenue by Country (2020-2025)
7.2 Europe Oncology Injection Drug Sales by Type (2020-2025)
7.3 Europe Oncology Injection Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Injection Drug by Country
8.1.1 Middle East & Africa Oncology Injection Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Oncology Injection Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Oncology Injection Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Oncology Injection Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oncology Injection Drug
10.3 Manufacturing Process Analysis of Oncology Injection Drug
10.4 Industry Chain Structure of Oncology Injection Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oncology Injection Drug Distributors
11.3 Oncology Injection Drug Customer
12 WORLD FORECAST REVIEW FOR ONCOLOGY INJECTION DRUG BY GEOGRAPHIC REGION
12.1 Global Oncology Injection Drug Market Size Forecast by Region
12.1.1 Global Oncology Injection Drug Forecast by Region (2026-2031)
12.1.2 Global Oncology Injection Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Oncology Injection Drug Forecast by Type (2026-2031)
12.7 Global Oncology Injection Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Taj Oncology
13.1.1 Taj Oncology Company Information
13.1.2 Taj Oncology Oncology Injection Drug Product Portfolios and Specifications
13.1.3 Taj Oncology Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Taj Oncology Main Business Overview
13.1.5 Taj Oncology Latest Developments
13.2 S.G. Biopharm
13.2.1 S.G. Biopharm Company Information
13.2.2 S.G. Biopharm Oncology Injection Drug Product Portfolios and Specifications
13.2.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 S.G. Biopharm Main Business Overview
13.2.5 S.G. Biopharm Latest Developments
13.3 AdvaCare
13.3.1 AdvaCare Company Information
13.3.2 AdvaCare Oncology Injection Drug Product Portfolios and Specifications
13.3.3 AdvaCare Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 AdvaCare Main Business Overview
13.3.5 AdvaCare Latest Developments
13.4 Merrimack
13.4.1 Merrimack Company Information
13.4.2 Merrimack Oncology Injection Drug Product Portfolios and Specifications
13.4.3 Merrimack Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merrimack Main Business Overview
13.4.5 Merrimack Latest Developments
13.5 Celgene
13.5.1 Celgene Company Information
13.5.2 Celgene Oncology Injection Drug Product Portfolios and Specifications
13.5.3 Celgene Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Celgene Main Business Overview
13.5.5 Celgene Latest Developments
13.6 Allos Therapeutics
13.6.1 Allos Therapeutics Company Information
13.6.2 Allos Therapeutics Oncology Injection Drug Product Portfolios and Specifications
13.6.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Allos Therapeutics Main Business Overview
13.6.5 Allos Therapeutics Latest Developments
13.7 Ferring Pharmaceuticals
13.7.1 Ferring Pharmaceuticals Company Information
13.7.2 Ferring Pharmaceuticals Oncology Injection Drug Product Portfolios and Specifications
13.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Ferring Pharmaceuticals Main Business Overview
13.7.5 Ferring Pharmaceuticals Latest Developments
13.8 Genzyme
13.8.1 Genzyme Company Information
13.8.2 Genzyme Oncology Injection Drug Product Portfolios and Specifications
13.8.3 Genzyme Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Genzyme Main Business Overview
13.8.5 Genzyme Latest Developments
13.9 Eli Lilly
13.9.1 Eli Lilly Company Information
13.9.2 Eli Lilly Oncology Injection Drug Product Portfolios and Specifications
13.9.3 Eli Lilly Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Eli Lilly Main Business Overview
13.9.5 Eli Lilly Latest Developments
13.10 Praecis Pharmaceuticals
13.10.1 Praecis Pharmaceuticals Company Information
13.10.2 Praecis Pharmaceuticals Oncology Injection Drug Product Portfolios and Specifications
13.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Praecis Pharmaceuticals Main Business Overview
13.10.5 Praecis Pharmaceuticals Latest Developments
13.11 Millennium Pharmaceuticals
13.11.1 Millennium Pharmaceuticals Company Information
13.11.2 Millennium Pharmaceuticals Oncology Injection Drug Product Portfolios and Specifications
13.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Millennium Pharmaceuticals Main Business Overview
13.11.5 Millennium Pharmaceuticals Latest Developments
13.12 Debiopharm
13.12.1 Debiopharm Company Information
13.12.2 Debiopharm Oncology Injection Drug Product Portfolios and Specifications
13.12.3 Debiopharm Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Debiopharm Main Business Overview
13.12.5 Debiopharm Latest Developments
13.13 Alza
13.13.1 Alza Company Information
13.13.2 Alza Oncology Injection Drug Product Portfolios and Specifications
13.13.3 Alza Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Alza Main Business Overview
13.13.5 Alza Latest Developments
13.14 CordenPharma
13.14.1 CordenPharma Company Information
13.14.2 CordenPharma Oncology Injection Drug Product Portfolios and Specifications
13.14.3 CordenPharma Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 CordenPharma Main Business Overview
13.14.5 CordenPharma Latest Developments
13.15 Pharmascience
13.15.1 Pharmascience Company Information
13.15.2 Pharmascience Oncology Injection Drug Product Portfolios and Specifications
13.15.3 Pharmascience Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Pharmascience Main Business Overview
13.15.5 Pharmascience Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Oncology Injection Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Oncology Injection Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Organs
Table 4. Major Players of Central Nervous System
Table 5. Major Players of Circulatory/Musculoskeletal System
Table 6. Major Players of Other
Table 7. Global Oncology Injection Drug Sales byType (2020-2025) & (K Pcs)
Table 8. Global Oncology Injection Drug Sales Market Share byType (2020-2025)
Table 9. Global Oncology Injection Drug Revenue byType (2020-2025) & ($ million)
Table 10. Global Oncology Injection Drug Revenue Market Share byType (2020-2025)
Table 11. Global Oncology Injection Drug Sale Price byType (2020-2025) & (USD/Pcs)
Table 12. Global Oncology Injection Drug Sale by Application (2020-2025) & (K Pcs)
Table 13. Global Oncology Injection Drug Sale Market Share by Application (2020-2025)
Table 14. Global Oncology Injection Drug Revenue by Application (2020-2025) & ($ million)
Table 15. Global Oncology Injection Drug Revenue Market Share by Application (2020-2025)
Table 16. Global Oncology Injection Drug Sale Price by Application (2020-2025) & (USD/Pcs)
Table 17. Global Oncology Injection Drug Sales by Company (2020-2025) & (K Pcs)
Table 18. Global Oncology Injection Drug Sales Market Share by Company (2020-2025)
Table 19. Global Oncology Injection Drug Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Oncology Injection Drug Revenue Market Share by Company (2020-2025)
Table 21. Global Oncology Injection Drug Sale Price by Company (2020-2025) & (USD/Pcs)
Table 22. Key Manufacturers Oncology Injection Drug Producing Area Distribution and Sales Area
Table 23. Players Oncology Injection Drug Products Offered
Table 24. Oncology Injection Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Oncology Injection Drug Sales by Geographic Region (2020-2025) & (K Pcs)
Table 28. Global Oncology Injection Drug Sales Market Share Geographic Region (2020-2025)
Table 29. Global Oncology Injection Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Oncology Injection Drug Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Oncology Injection Drug Sales by Country/Region (2020-2025) & (K Pcs)
Table 32. Global Oncology Injection Drug Sales Market Share by Country/Region (2020-2025)
Table 33. Global Oncology Injection Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Oncology Injection Drug Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Oncology Injection Drug Sales by Country (2020-2025) & (K Pcs)
Table 36. Americas Oncology Injection Drug Sales Market Share by Country (2020-2025)
Table 37. Americas Oncology Injection Drug Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Oncology Injection Drug Sales byType (2020-2025) & (K Pcs)
Table 39. Americas Oncology Injection Drug Sales by Application (2020-2025) & (K Pcs)
Table 40. APAC Oncology Injection Drug Sales by Region (2020-2025) & (K Pcs)
Table 41. APAC Oncology Injection Drug Sales Market Share by Region (2020-2025)
Table 42. APAC Oncology Injection Drug Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Oncology Injection Drug Sales byType (2020-2025) & (K Pcs)
Table 44. APAC Oncology Injection Drug Sales by Application (2020-2025) & (K Pcs)
Table 45. Europe Oncology Injection Drug Sales by Country (2020-2025) & (K Pcs)
Table 46. Europe Oncology Injection Drug Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Oncology Injection Drug Sales byType (2020-2025) & (K Pcs)
Table 48. Europe Oncology Injection Drug Sales by Application (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Oncology Injection Drug Sales by Country (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Oncology Injection Drug Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Oncology Injection Drug Sales byType (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Oncology Injection Drug Sales by Application (2020-2025) & (K Pcs)
Table 53. Key Market Drivers & Growth Opportunities of Oncology Injection Drug
Table 54. Key Market Challenges & Risks of Oncology Injection Drug
Table 55. Key IndustryTrends of Oncology Injection Drug
Table 56. Oncology Injection Drug Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Oncology Injection Drug Distributors List
Table 59. Oncology Injection Drug Customer List
Table 60. Global Oncology Injection Drug SalesForecast by Region (2026-2031) & (K Pcs)
Table 61. Global Oncology Injection Drug RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Oncology Injection Drug SalesForecast by Country (2026-2031) & (K Pcs)
Table 63. Americas Oncology Injection Drug Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Oncology Injection Drug SalesForecast by Region (2026-2031) & (K Pcs)
Table 65. APAC Oncology Injection Drug Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Oncology Injection Drug SalesForecast by Country (2026-2031) & (K Pcs)
Table 67. Europe Oncology Injection Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Oncology Injection Drug SalesForecast by Country (2026-2031) & (K Pcs)
Table 69. Middle East & Africa Oncology Injection Drug RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Oncology Injection Drug SalesForecast byType (2026-2031) & (K Pcs)
Table 71. Global Oncology Injection Drug RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Oncology Injection Drug SalesForecast by Application (2026-2031) & (K Pcs)
Table 73. Global Oncology Injection Drug RevenueForecast by Application (2026-2031) & ($ millions)
Table 74.Taj Oncology Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 75.Taj Oncology Oncology Injection Drug Product Portfolios and Specifications
Table 76.Taj Oncology Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 77.Taj Oncology Main Business
Table 78.Taj Oncology Latest Developments
Table 79. S.G. Biopharm Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. S.G. Biopharm Oncology Injection Drug Product Portfolios and Specifications
Table 81. S.G. Biopharm Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 82. S.G. Biopharm Main Business
Table 83. S.G. Biopharm Latest Developments
Table 84. AdvaCare Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. AdvaCare Oncology Injection Drug Product Portfolios and Specifications
Table 86. AdvaCare Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 87. AdvaCare Main Business
Table 88. AdvaCare Latest Developments
Table 89. Merrimack Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Merrimack Oncology Injection Drug Product Portfolios and Specifications
Table 91. Merrimack Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 92. Merrimack Main Business
Table 93. Merrimack Latest Developments
Table 94. Celgene Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Celgene Oncology Injection Drug Product Portfolios and Specifications
Table 96. Celgene Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 97. Celgene Main Business
Table 98. Celgene Latest Developments
Table 99. AllosTherapeutics Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. AllosTherapeutics Oncology Injection Drug Product Portfolios and Specifications
Table 101. AllosTherapeutics Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 102. AllosTherapeutics Main Business
Table 103. AllosTherapeutics Latest Developments
Table 104.Ferring Pharmaceuticals Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 105.Ferring Pharmaceuticals Oncology Injection Drug Product Portfolios and Specifications
Table 106.Ferring Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 107.Ferring Pharmaceuticals Main Business
Table 108.Ferring Pharmaceuticals Latest Developments
Table 109. Genzyme Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Genzyme Oncology Injection Drug Product Portfolios and Specifications
Table 111. Genzyme Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 112. Genzyme Main Business
Table 113. Genzyme Latest Developments
Table 114. Eli Lilly Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Eli Lilly Oncology Injection Drug Product Portfolios and Specifications
Table 116. Eli Lilly Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 117. Eli Lilly Main Business
Table 118. Eli Lilly Latest Developments
Table 119. Praecis Pharmaceuticals Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Praecis Pharmaceuticals Oncology Injection Drug Product Portfolios and Specifications
Table 121. Praecis Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 122. Praecis Pharmaceuticals Main Business
Table 123. Praecis Pharmaceuticals Latest Developments
Table 124. Millennium Pharmaceuticals Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Millennium Pharmaceuticals Oncology Injection Drug Product Portfolios and Specifications
Table 126. Millennium Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 127. Millennium Pharmaceuticals Main Business
Table 128. Millennium Pharmaceuticals Latest Developments
Table 129. Debiopharm Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 130. Debiopharm Oncology Injection Drug Product Portfolios and Specifications
Table 131. Debiopharm Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 132. Debiopharm Main Business
Table 133. Debiopharm Latest Developments
Table 134. Alza Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 135. Alza Oncology Injection Drug Product Portfolios and Specifications
Table 136. Alza Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 137. Alza Main Business
Table 138. Alza Latest Developments
Table 139. CordenPharma Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 140. CordenPharma Oncology Injection Drug Product Portfolios and Specifications
Table 141. CordenPharma Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 142. CordenPharma Main Business
Table 143. CordenPharma Latest Developments
Table 144. Pharmascience Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors
Table 145. Pharmascience Oncology Injection Drug Product Portfolios and Specifications
Table 146. Pharmascience Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 147. Pharmascience Main Business
Table 148. Pharmascience Latest Developments
LIST OFFIGURES
Figure 1. Picture of Oncology Injection Drug
Figure 2. Oncology Injection Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oncology Injection Drug Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Oncology Injection Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Oncology Injection Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Oncology Injection Drug Sales Market Share by Country/Region (2024)
Figure 10. Oncology Injection Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Organs
Figure 12. Product Picture of Central Nervous System
Figure 13. Product Picture of Circulatory/Musculoskeletal System
Figure 14. Product Picture of Other
Figure 15. Global Oncology Injection Drug Sales Market Share byType in 2025
Figure 16. Global Oncology Injection Drug Revenue Market Share byType (2020-2025)
Figure 17. Oncology Injection Drug Consumed in Lymphoma
Figure 18. Global Oncology Injection Drug Market: Lymphoma (2020-2025) & (K Pcs)
Figure 19. Oncology Injection Drug Consumed in Myeloma
Figure 20. Global Oncology Injection Drug Market: Myeloma (2020-2025) & (K Pcs)
Figure 21. Oncology Injection Drug Consumed in Prostate Cancer
Figure 22. Global Oncology Injection Drug Market: Prostate Cancer (2020-2025) & (K Pcs)
Figure 23. Oncology Injection Drug Consumed in Other
Figure 24. Global Oncology Injection Drug Market: Other (2020-2025) & (K Pcs)
Figure 25. Global Oncology Injection Drug Sale Market Share by Application (2024)
Figure 26. Global Oncology Injection Drug Revenue Market Share by Application in 2025
Figure 27. Oncology Injection Drug Sales by Company in 2025 (K Pcs)
Figure 28. Global Oncology Injection Drug Sales Market Share by Company in 2025
Figure 29. Oncology Injection Drug Revenue by Company in 2025 ($ millions)
Figure 30. Global Oncology Injection Drug Revenue Market Share by Company in 2025
Figure 31. Global Oncology Injection Drug Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Oncology Injection Drug Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Oncology Injection Drug Sales 2020-2025 (K Pcs)
Figure 34. Americas Oncology Injection Drug Revenue 2020-2025 ($ millions)
Figure 35. APAC Oncology Injection Drug Sales 2020-2025 (K Pcs)
Figure 36. APAC Oncology Injection Drug Revenue 2020-2025 ($ millions)
Figure 37. Europe Oncology Injection Drug Sales 2020-2025 (K Pcs)
Figure 38. Europe Oncology Injection Drug Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Oncology Injection Drug Sales 2020-2025 (K Pcs)
Figure 40. Middle East & Africa Oncology Injection Drug Revenue 2020-2025 ($ millions)
Figure 41. Americas Oncology Injection Drug Sales Market Share by Country in 2025
Figure 42. Americas Oncology Injection Drug Revenue Market Share by Country (2020-2025)
Figure 43. Americas Oncology Injection Drug Sales Market Share byType (2020-2025)
Figure 44. Americas Oncology Injection Drug Sales Market Share by Application (2020-2025)
Figure 45. United States Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Oncology Injection Drug Sales Market Share by Region in 2025
Figure 50. APAC Oncology Injection Drug Revenue Market Share by Region (2020-2025)
Figure 51. APAC Oncology Injection Drug Sales Market Share byType (2020-2025)
Figure 52. APAC Oncology Injection Drug Sales Market Share by Application (2020-2025)
Figure 53. China Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. India Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 59. ChinaTaiwan Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Oncology Injection Drug Sales Market Share by Country in 2025
Figure 61. Europe Oncology Injection Drug Revenue Market Share by Country (2020-2025)
Figure 62. Europe Oncology Injection Drug Sales Market Share byType (2020-2025)
Figure 63. Europe Oncology Injection Drug Sales Market Share by Application (2020-2025)
Figure 64. Germany Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 65.France Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Oncology Injection Drug Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Oncology Injection Drug Sales Market Share byType (2020-2025)
Figure 71. Middle East & Africa Oncology Injection Drug Sales Market Share by Application (2020-2025)
Figure 72. Egypt Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 75.Turkey Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Oncology Injection Drug Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Oncology Injection Drug in 2025
Figure 78. Manufacturing Process Analysis of Oncology Injection Drug
Figure 79. Industry Chain Structure of Oncology Injection Drug
Figure 80. Channels of Distribution
Figure 81. Global Oncology Injection Drug Sales MarketForecast by Region (2026-2031)
Figure 82. Global Oncology Injection Drug Revenue Market ShareForecast by Region (2026-2031)
Figure 83. Global Oncology Injection Drug Sales Market ShareForecast byType (2026-2031)
Figure 84. Global Oncology Injection Drug Revenue Market ShareForecast byType (2026-2031)
Figure 85. Global Oncology Injection Drug Sales Market ShareForecast by Application (2026-2031)
Figure 86. Global Oncology Injection Drug Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global DNA Damage Response Drugs Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
113 pages
Global Bed Monitoring Systems Market Growth 2023-2029
US$ 3,660.00
March 2023
94 pages
Global Drug Discovery Services Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
92 pages
Global Portable C-Arm Market Growth 2024-2030
US$ 3,660.00
October 2024
139 pages
Global Joint Replacement Surgery Robots Market Growth 2023-2029
US$ 3,660.00
March 2023
100 pages
